Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 7 (INTS7) is a protein-coding gene that encodes a core component of the Integrator complex, which regulates RNA polymerase II–dependent transcription by mediating 3'-end processing of small nuclear RNAs such as U1 and U2 snRNAs. The Integrator complex forms a scaffold for both nuclease and phosphatase modules, and INTS7 is part of the backbone module together with INTS1 and INTS2. INTS7 is implicated in cellular responses to DNA damage where it participates in ATR signaling, and its expression is associated with disease aggressiveness in cancer types such as prostate and gastric cancer. It also modulates bone marrow mesenchymal stem cell differentiation and proliferation, indicating roles outside of classic RNA processing. INTS7 is not itself an enzyme, receptor, transporter, or current therapeutic target; it functions as an essential structural protein within a much larger multiprotein complex [1][2][3].
Not applicable; INTS7 is not an established drug target. Its function is as part of a protein complex, not as a direct target of small molecules or biologics [1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 7 (INTS7).